LUCA2 and antibodies that bind thereto
US7847070B2 · kind B2 · utility
0Cited by
23References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 31, 2006 |
| Grant date | Dec 7, 2010 |
| Priority date | — |
| Expiry date | Jan 6, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/77
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides the identification and characterization of disease and cancer-associated antigen, LUCA2. The invention also provides a family of monoclonal antibodies that bind to antigen LUCA2, methods of diagnosing and treating various human cancers and diseases that express LUCA2.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.